Naples, January 29, 2026 – Thyroid pathologies represent one of the most significant public health issues in Italy today. Naples is once again drawing attention to this critical matter by hosting one of the most important national scientific events dedicated to thyroid diagnosis, therapy, and surgery on January 29 and 30, 2026.
The Scope of Thyroid Disorders in Italy
According to the latest data, approximately 10% of the Italian population suffers from thyroid disorders, while the incidence of thyroid nodules exceeds 50%. Furthermore, malignant thyroid tumors are the most frequent endocrine system neoplasm. These figures underscore why the topic is central to the XI Update Workshop in Thyroid Surgery, a reference event for endocrinologists and surgeons, bringing together leading Italian specialists in the Campania capital.
“50 Shades of Grey”: Addressing Clinical Uncertainties
The chosen title for the 2026 edition, “50 Shades of Grey in Thyroid Pathologies of Surgical and Non-Surgical Interest,” is not coincidental. It deliberately alludes to the numerous areas of clinical uncertainty that still characterize the management of these pathologies, despite the existence of national and international guidelines.
The congress is chaired by Giovanni Docimo, Professor of General Surgery and Head of the Thyroid Unit at the University of Campania Luigi Vanvitelli, as well as past president of the Italian Unitary Society of Endocrine Surgery. “It is a source of pride to present the XI edition of the workshop,” Docimo emphasized, “which this year is enriched by the active participation of the Association of Medical Endocrinologists. I also thank the Italian Unitary Society of Endocrine Surgery and the Italian Society of Surgery, who confirm their patronage.”
Evolution of Diagnostics and Treatment, Challenges Remain
Over the past twenty years, thyroid diagnostics, surgical indications, and therapeutic pathways have undergone profound evolution, enabling very high cure rates and increasingly personalized strategies. However, crucial questions remain open: when to intervene surgically, which technique to choose, what are the real diagnostic and therapeutic innovations, and, above all, how to correctly guide the patient.
“Many ‘grey areas’ persist,” explains Docimo, “leading to different and not always unequivocal decisions. The multidisciplinary approach today represents the true gold standard for identifying the most suitable treatment for each individual patient.”
The Neapolitan workshop therefore aims to be a moment of high-level scientific discussion, capable of offering concrete answers to still open questions and strengthening the dialogue between surgery, endocrinology, and personalized medicine, placing the individual at the center, not just the pathology.
Source: sudnotizie.com
